Sign inLaunch App
BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·
Company pair · Health
VS

BioLinq vs Egenesis

Health Both private US-headquartered No Canborsa market

This comparison puts BioLinq next to Egenesis within health on size, funding and trajectory.

On this pageSide by sideValuation marksWhat each disclosesVerdictFAQ
BioLinqPRIVATE · US
EgenesisPRIVATE · US
VS
Last valuation$400M$350M
Basis Post-money Post-money
As ofApr 2025Feb 2021
Founded20102015
Employees≈118≈200
On CanborsaNo marketNo market
At a glance
$400M
BioLinqPost-money, Series C · Apr 2025
$350M
EgenesisPost-money, Series C · Feb 2021
1.14×
GapBoth post-money, 50 months apart
0 of 2
On CanborsaNeither company has a market
VS
Head-to-head · field by field

BioLinq vs Egenesis — side by side

Field
BioLinqPRIVATE · FOUNDED 2010
EgenesisPRIVATE · FOUNDED 2015
VS
Last valuation
$400M Post-money
$350M Post-money
Valuation date
22 Apr 2025
1 Feb 2021
Valuation basis
Post-money
Post-money
Latest round
Series C
Series C
Round size
$100M
$125M
Named investors
RiverVest Venture Partners AXA IM Alts LifeSci Venture Partners M Ventures
Lux Capital ARCH Ventures Khosla Ventures Farallon Capital
Founded
2010
2015
Employees (est.)
≈118
≈200
Sector & HQ
Medical Devices / Biotech · 🇺🇸 US
Biotechnology / Healthcare · 🇺🇸 US
Status & market
Private — no Canborsa market
Private — no Canborsa market
Valuation · both companies on one scale

Valuation marks

Each bar is the last disclosed mark — $400M for BioLinq (post-money, Apr 2025) and $350M for Egenesis (post-money, Feb 2021).

BioLinq
$400MPost-money · Apr 2025
Egenesis
$350MPost-money · Feb 2021
BIOLINQ · $400M · APR 2025EGENESIS · $350M · FEB 2021
BioLinq vs Egenesis · what each company discloses

What each company discloses, and what it leaves out

BioLinqPRIVATEHealth · US · 2010
+Last disclosed mark $400M — post-money, Apr 2025.
+Founded 2010 .
+≈118 employees.
+Latest round: Series C, $100M raised, led by Alpha Wave Ventures.
EgenesisPRIVATEHealth · US · 2015
+Last disclosed mark $350M — post-money, Feb 2021.
+Founded 2015 .
+≈200 employees.
+Latest round: Series C, $125M raised.
Verdict

Verdict

The $400M tells you…
What an investor paid for newly issued shares — a primary round, priced post-money.
How much capital arrived with it:$100M, led by Alpha Wave Ventures in Apr 2025.
A dated print: it moves only when a newer round is announced.
The $350M tells you…
What an investor paid for newly issued shares — a primary round, priced post-money.
How much capital arrived with it:$125Min Feb 2021.
A dated print: it moves only when a newer round is announced.

Both marks are post-money, so 1.14× compares like with like. Both are private: there is no public quote and no Canborsa market on either name.

Frequently asked questions

What industries are BioLinq and Egenesis in?›

BioLinq operates in Medical Devices / Biotech, and Egenesis operates in Biotechnology / Healthcare.

What is BioLinq's valuation versus Egenesis'?›

BioLinq is valued at $400M, and Egenesis at $350M.

What's the total funding raised by BioLinq versus Egenesis?›

BioLinq has raised $272.8M across 5 rounds, and Egenesis has raised $554M across 5 rounds.

What's the team size at BioLinq versus Egenesis?›

BioLinq has about 118 employees, and Egenesis has about 200.

Where are BioLinq and Egenesis incorporated?›

BioLinq is headquartered in United States, and Egenesis in United States.

Same pillar · company pairs

Neighbouring pairs in this sector

BioLinq vs Kriya Therapeuticscompany pair · health›
$400Mtop valuation2.0×gap
BioLinq vs Calyxocompany pair · health›
$684.6Mtop valuation1.7×gap
Calyxo vs Egenesiscompany pair · health›
$684.6Mtop valuation2.0×gap
Benchling vs Solugencompany pair · health›
$6.1Btop valuation3.0×gap
Abridge vs HistoSonicscompany pair · health›
$5.3Btop valuation2.4×gap
Alloy Therapeutics vs Zocdoccompany pair · health›
$1.8Btop valuation1.8×gap
HistoSonics vs Neuralinkcompany pair · health›
$9Btop valuation4.0×gap
Abridge vs Alloy Therapeuticscompany pair · health›
$5.3Btop valuation5.3×gap
Keep exploring
More pairs in Health
Calyxo vs Kriya Therapeuticscompare · versus›Benchling vs Signoscompare · versus›Benchling vs Pristyn Carecompare · versus›HistoSonics vs Zocdoccompare · versus›All company comparisonsindex›
Learn
Stock perps vs tokenized stocksconcept›RWA perpetualsmarkets · index›Perpetuals vs futuresconcept›What is a perpetual?guide · perpetuals basics›All Learn guideslearn · index›
Listed on Canborsa
SpaceX (SPCX)US equity · perp›Cerebras Systems (CBRS)US equity · perp›NVIDIA (NVDA)US equity · perp›Microsoft (MSFT)US equity · perp›All 86 marketsindex›
Company pair · Health

Trade 86 markets on Canborsa

Canborsa

Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.

Markets
Crypto perpetualsStock perpetualsGold & commoditiesIndex perpetualsAll markets ›
Companies
SpaceXOpenAIAnthropicStripeAll companies ›
Compare
Perp feesFunding ratesNo-KYC platformsCanborsa vs AvantisCanborsa vs OstiumAll comparisons ›
Learn
What is a perpetual?Funding rates explainedAirdrops & pointsAll guides ›
© Canborsa 2026TermsPrivacy